Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward

Video   Aug 18, 2015

 

About the Speaker


Prof. Gallagher is currently the Chief Scientific Officer (CSO) at OncoMark. A major focus of Prof. Gallagher’s research work is the identification and validation of candidate biomarkers of breast cancer and melanoma, with particular emphasis on translation of transcriptomic and proteomic datasets into clinically relevant assays. In addition, his team (the Cancer Biology and Therapeutics Lab; www.cbtlab.ie) investigates the functional relevance of candidate tumour progression-associated genes at both in vitro and in vivo levels, as well as engages in preclinical evaluation of novel anti-cancer agents.Abstract
This presentation will cover how bottlenecks in the validation of candidate tumour progression-related biomarkers can be overcome. In particular, the use of tissue microarray technology and digital pathology will be highlighted. In addition, a novel mechanistically anchored biomarker panel that outcompetes current prognostic classifiers in breast cancer will be introduced for the first time.

 
 
 
 

Recommended Videos

Scientist Feedback on the NanoDrop One Microvolume UV-Vis Spectrophotometer

Video

Watch this testimonial video with a University of Cambridge scientist who studies the chemical biology of nucleic acids.

WATCH NOW

The All New Affinity ITC - Perfected ITC Automation

Video

While others have attempted ITC automation, leading to bent syringes and imperfect data, TA Instruments has perfected it with the all new Affinity ITC!

WATCH NOW

Combating Infectious Diseases with Next-generation Sequencing

Video

Learn how next-gen sequencing is accelerating the process of diagnosing mysterious infectious diseases and helping doctors to deliver life-saving treatments.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE